Entrada Therapeutics
TRDA
TRDA
77 hedge funds and large institutions have $369M invested in Entrada Therapeutics in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 3 closing their positions.
Holders
77
Holders Change
+15
Holders Change %
+24.19%
% of All Funds
1.12%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
18
Increased
19
Reduced
23
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
American Century Companies
Kansas City,
Missouri
|
$5.19M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$987K |
| 3 |
3
Citigroup
New York
|
$798K |
| 4 |
4
Marshall Wace
London,
United Kingdom
|
$733K |
| 5 |
5
Millennium Management
New York
|
$1.02M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AWM
76
Avior Wealth Management
Omaha,
Nebraska
| $56 | 4 | +4 | New |
|
|
7IH
77
72 Investment Holdings
Stamford,
Connecticut
| – | – | -172,600 | Closed |
|
78
Mirae Asset Global Investments
Seoul,
South Korea
| – | – | -10,874 | Closed |
|
|
SOW
79
State of Wyoming
Cheyenne,
Wyoming
| – | – | -5,932 | Closed |
|
|
CFGS
80
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
81
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $0 | 1 | +1 | New |
|